Clindamycin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Skin and soft tissue infections caused by streptococci, staphylococci, and anaerobes.
  • Pelvic infections (endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infections)
  • Streptococcus pneumoniae (empyema, pneumonitis, and lung abscess)
  • Septicemia (no longer recommended)
  • Intra-abdominal infections such as peritonitis and intra-abdominal abscess caused by anaerobes (note: IDSA no longer recommends clindamycin due to increased B. fragilis resistance rate)
  • Acne vulgaris (topical gel)
  • Bacterial vaginosis in non-pregnant women (vaginal ovules)

NON-FDA APPROVED USES

  • PCP in combination with primaquine
  • CNS toxoplasmosis in combination with pyrimethamine and leucovorin
  • Bacterial vaginosis (oral and vaginal ovule)
  • Community acquired MRSA (CA-MRSA) soft tissue infections
  • Osteomyelitis
  • Actinomycosis
  • Acute bacterial sinusitis
  • CA-MRSA pneumonia in combination with vancomycin to reduce toxin production in severe cases.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 10, 2011